47 -5 (55) 2023 — Ergashov B.B. — ARRHYTHMIAS IN PATIENTS WITH CANCER

ARRHYTHMIAS IN PATIENTS WITH CANCER

Ergashov B.B. Bukhara State Medical Institute named after Abu Ali ibn Sina

Rezume

Arrhythmias are often detected in cancer patients receiving treatment. The proposed review examines rhythm disturbances by the type of tachyarrhythmias, most often found in cancer patients, as well as their features, characteristic directly for oncological diseases, and emphasizes the importance of ECG monitoring for early diagnosis, treatment and monitoring of this cohort of patients who are more susceptible to the development of proarrhythmia. Oncologists should be fully aware of possible cardiac arrhythmias, and close cooperation between cardiologists and oncologists will lead to better stratification of the risk of developing cardiovascular diseases, monitoring and treatment.

Keywords: tachyarrhythmia, oncology, chemotherapy, arrhythmogenic effect, supraventricular tachycardia, ventricular tachycardia, cardioncology, cardiotoxicity.

First page

272

Last page

280

For citation: Ergashov B.B. – ARRHYTHMIAS IN PATIENTS WITH CANCER //New Day in Medicine 2023 5(55): 272-280 https://newdaymedicine.com/index.php/2023/06/05/l-81/

LIST OF REFERENCES:

  1. Beheiry S., Al-Ahmad A.,  Natale A. (2021). Atrial fibrillation and flutter: Diagnosis and treatment. In A. Tsiperfal, L.K. Ottoboni, S. Beheiry, A.Al-Ahmad, A. Natale, P. Wang (Eds.), Cardiac arrhythmia management: A practical guide for nurses and allied professionals 2021 85-100. Chichester, West Sussex, UK: Wiley-Blackwell.
  2. Chugh S.S., Blackshear J.L., Shen W.K., Hammill S.C., Gersh B.J. (2011). Epidemiology and natural history of atrial fibrillation: Clinical implications. Journal of the American College of Cardiology, 2021 37:371-378.
  3. Ciriaco P., Mazzone P., Canneto B., Zannini P. (2010). Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone. European Journal of Cardio-Thoracic Surgery 2010 18:12-16.
  4. Epstein A.E., DiMarco J.P., Ellenbogen K.A., Estes N.A., 3rd, Freedman R.A., Gettes L.S., Yancy C.W. (2008). АСС/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2012 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 2008 51(21):el-e62.
  5. Falk R.H., Dubrey S.W. (2020). Amyloid heart disease. In M.A. Gertz S.V. Rajkumar (Eds.), Amyloidosis: Diagnosis and treatment 2020 107-128. New York, NY: Humana Press.
  6. Fuster V., Ryden L.E., Asinger R.W., Cannom D.S., Crijns H .J., Frye R.L., Torbicki A. (2001). АСС/AHA/LSC guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiology/American Heart European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation, 2001 104:2118-2150.
  7. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Wann L.S., (2021). 2021ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed In partnership with die European Society of Cardiology and In collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Journal of the American College of Cardiology, 2021 57:el01-el98.
  8. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., Singer D.E. (2011). Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 2011 285:2370-2375.
  9. Granada J., Uribe W., Chyou P.H., Maassen K., Vierkant R., Smith P.N., Vidaillet H. (2010). Incidence and predictors of atrial flutter in the general population. Journal of the American College of Cardiology, 2010 36:2242-2246.
  10. Hidalgo J.D., Krone R., Rich M.W., Blum K., Adkins D., Fan M.Y., Khoury H. (2014). Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: Incidence, risk factors and outcomes. Bone Marrow Transplantation, 2014 34:615-619.
  11. Hollings D.D., Higgins R.S.D., Faber L.P., Warren W.H., Liptay M.J., Basu S., Kim A.W. (2020). Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy. American Journal of Surgery, 2020 199:558-561.
  12. Ma J.-Y, Wang Y., Zhao Y.-E, Wu Z„ Liu L.-X., Kou Y.-L., Yang J.J. (2016). Atrial fibrillation after surgery for esophageal carcinoma: Clinical and prognostic significance. World Journal of Gastroenterology, 2016 12:449-452.
  13. Menard O., Martinet Y., Lamy P. (1991). Cisplatin-induced atrial fibrillation. Journal of Clinical Oncology, 1991 192-193.
  14. Miller J.M., Zipes D.P. (2012). Therapy for cardiac arrhythmias. In R.O. Bonow, D.L. Mann, D.P. Zipes, P. Libby (Eds.), Braunwald’s heart disease: A textbook of cardiovascular medicine 2012 9:771-823. Philadelphia
  15. Montella L., Caraglia M., Addeo R., Costanzo R., Faiola V., Abbruzzese A., Del Prete S. (2005). Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert’s disease). Annals of Hematology, 2005 84:192-193.
  16. Murthy S.C., Law S. Whooley B.P., Alexandrou A., Chu K.-M., Wong J. (2003). Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. Journal of Thoracic and Cardiovascular Surgery, 2003 126:1162-1167.
  17. Olgin J., Zipes D.P. (2012). Therapy for cardiac arrhythmias. In R.O. Bonow, D.L. Mann, D.P.Zipes. P.I. Libby (Eds.), Braunwald’s heart disease: A textbook of cardiovascular medicine 2012 9:710-743. Philadelphia, W.B. Saunders.
  18. Olivieri A., Corvatta L., Montanari M., Brunori M., Offidani M., Ferretti G.F., Leoni P. (1998). Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. Bone Marrow Transplantation, 1998 21:1049-1053.
  19. Olshansky B., Rosenfeld L.E., Warner A.L., Solomon A.J., O’Neill G., Sharma A., Greene H.L. (2004). The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: Approaches to control rate in atrial fibrillation. Journal of the American College of Cardiology, 2004 43:1201-1208.
  20. Onaitis M., D’Amico T., Zhao Y., O’Brien S., Harpole D. (2010). Risk factors for atrial fibrillation after lung cancer surgery: Analysis of the Society of Thoracic Surgeons general thoracic surgery database. Annals of Thoracic Surgery, 2010 90:368-374.

file

download